Aytu bioscience, inc (AYTU)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Feb'15Nov'14Aug'14Jun'14May'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11
Assets
Current assets
Cash and cash equivalents

62,264

5,259

7,014

11,044

14,647

17,804

3,964

7,012

12,006

3,908

7,021

802

3,470

5,230

2,749

8,054

8,665

10,959

10,069

7,353

1,491

-

-

-

2,639

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

251

251

250

250

100

100

100

100

-

-

-

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

75

75

75

-

75

75

75

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

10,203

5,197

1,705

1,740

1,376

1,482

760

578

732

1,377

1,211

528

342

582

509

162

84

288

167

157

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory, net

3,854

2,491

1,380

1,440

1,530

1,644

1,310

1,338

883

1,379

1,171

1,312

208

438

585

524

621

653

494

39

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other

4,830

2,361

573

957

804

944

736

440

896

1,003

262

310

342

436

553

215

-

-

-

370

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable

-

1,350

1,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

1,849

1,426

59

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

8

2

-

8

0

0

1

0

3

0

0

0

0

1

3

Prepaid expenses and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

943

741

360

-

25

7

0

0

521

0

0

0

0

0

0

0

0

0

0

0

0

Prepaid research and development - related party (Note 11)

-

-

-

-

-

-

-

-

-

-

-

-

0

121

121

121

121

121

121

121

121

-

-

-

121

-

-

-

-

-

-

-

-

-

-

-

-

Investment in Acerus

-

-

-

-

-

-

-

-

-

-

-

-

0

1,272

1,769

1,041

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94

-

-

-

-

-

18

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

83,254

18,337

11,982

15,432

18,458

21,977

6,872

9,470

14,594

7,744

9,742

3,028

4,438

8,157

6,363

10,120

10,436

12,764

11,307

8,042

1,650

7

9

2

3,301

9

0

0

1

0

3

0

0

0

1

1

4

Fixed assets, net

288

122

137

203

219

186

196

218

260

560

566

647

271

292

313

231

196

143

26

29

36

0

1

2

57

3

5

6

7

8

9

11

12

13

15

16

18

Right-of-use-asset

675

374

393

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Developed technology, net

-

-

-

-

-

-

-

-

19

1,254

1,294

1,337

641

1,076

1,118

1,159

1,201

1,242

760

780

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Customer contracts, net

-

-

-

-

-

-

-

-

0

74

76

77

585

1,249

1,301

1,353

1,405

1,456

693

711

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade names, net

-

-

-

-

-

-

-

-

2

152

158

164

65

178

186

194

202

210

77

79

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licensed assets, net

17,155

17,724

18,293

18,861

19,430

19,999

10,674

11,120

8,242

8,571

8,901

9,231

9,560

9,890

10,220

10,549

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,500

7,500

7,500

7,500

-

-

-

-

7,500

-

-

-

-

-

-

-

-

-

-

-

-

In-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patents and tradenames, net

11,724

207

214

220

226

233

239

245

252

258

264

271

277

283

290

296

575

593

611

628

646

-

-

-

699

-

-

-

-

-

-

-

-

-

-

-

-

Product technology rights, net

21,754

22,321

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of prepaid research and development - related party (Note 11)

-

-

-

-

-

-

-

-

-

-

-

-

0

152

182

213

243

274

304

335

365

-

-

-

457

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

38

2

2

2

2

2

2

5

2

2

2

2

2

2

2

2

2

2

4

4

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

24,061

15,387

-

0

-

-

-

-

0

238

238

238

74

221

221

221

221

221

74

74

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term assets

75,699

56,139

19,041

19,288

19,879

20,421

11,112

11,589

8,779

11,113

11,503

11,969

11,478

13,348

13,837

14,222

11,549

11,645

10,051

10,142

8,551

-

-

-

8,714

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

-

-

0

-

-

-

-

Total assets

158,953

74,477

31,024

34,721

38,338

42,399

17,984

21,060

23,374

18,858

21,245

14,998

15,916

21,506

20,200

24,343

21,985

24,409

21,359

18,185

10,201

7

11

5

12,016

13

5

7

9

9

13

11

12

14

16

18

22

Liabilities
Current liabilities
Accounts payable and other

6,956

9,598

2,632

2,133

2,131

2,371

2,111

2,119

3,199

3,414

1,660

2,220

1,408

-

-

2,322

-

-

-

-

546

4

3

0

-

3

11

12

6

7

14

12

5

4

3

5

0

Accrued liabilities

9,830

2,114

1,151

1,311

772

932

428

185

211

257

903

782

1,050

-

-

1,197

-

-

-

-

-

1

1

1

-

0

12

0

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

2,445

2,507

-

1,177

1,076

1,075

1,195

-

-

-

-

649

-

-

-

-

-

-

-

-

-

-

-

-

Natesto payable

-

-

-

-

-

-

-

-

-

-

-

-

0

4,000

5,685

5,379

-

-

-

0

468

-

-

-

561

-

-

-

-

-

-

-

-

-

-

-

-

Primsol payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,154

1,111

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities-related party (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

-

-

-

-

-

-

-

-

-

-

-

-

Accrued compensation

2,210

786

1,002

849

791

743

796

540

898

837

680

339

845

519

532

1,200

787

492

617

196

98

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current lease liability

289

82

79

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current deferred revenue

-

-

-

-

-

13

-

-

-

-

-

-

-

-

-

-

85

85

85

85

85

-

-

-

85

-

-

-

-

-

-

-

-

-

-

-

-

Current deferred rent

-

-

-

-

0

0

0

1

3

4

6

6

-

-

-

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

6

6

5

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current contingent consideration

947

705

1,236

1,078

808

593

249

547

29

286

257

261

4,037

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of fixed payment arrangements

17,395

2,661

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of CVR liabilities

786

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, net

3,617

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tuition deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-

Accrued interest payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

18

17

-

17

16

14

-

11

10

9

-

7

6

5

5

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Accrued interest payable, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

-

-

-

8

-

-

-

-

Related party payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

-

-

-

36

31

30

-

28

113

104

99

96

83

72

68

55

55

55

52

Notes to Ampio

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,000

-

-

-

4,600

-

-

-

-

-

-

-

-

-

-

-

-

Interest payable to Ampio

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

-

-

46

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

42,032

15,949

6,102

5,372

4,503

4,655

3,587

3,394

4,341

4,800

3,508

3,610

3,354

6,971

8,730

10,104

3,205

2,804

1,777

1,477

9,202

60

55

50

6,092

49

153

133

120

115

107

94

82

68

65

66

58

Convertible promissory notes, net of amortization discount of $1,040,203 (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

4,921

4,825

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term contingent consideration, net of current portion

17,806

17,739

22,272

22,247

12,633

12,783

4,220

4,146

6,162

7,726

7,566

7,386

42

4,003

3,929

3,869

698

687

677

664

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term lease liability, net of current portion

804

291

314

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term fixed payment arrangements, net of current portion

8,162

23,394

-

0

5,134

5,036

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term CVR liabilities, net of current portion

4,432

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

361

383

404

425

447

-

-

-

511

-

-

-

-

-

-

-

-

-

-

-

-

Interest payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

66

161

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deferred rent

-

-

-

-

-

-

-

-

0

0

0

1

3

4

6

8

12

11

11

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-current deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94

-

-

-

-

-

42

-

-

-

-

-

-

-

-

-

-

-

-

Warrant derivative liability

11

11

11

13

28

25

46

93

120

3,300

3,818

0

0

79

346

275

66

180

102

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

73,249

57,387

28,700

27,633

22,300

22,501

7,854

7,635

10,624

15,827

14,892

10,998

7,395

11,059

13,013

14,257

4,419

9,151

7,950

2,568

9,650

-

-

-

6,646

-

-

-

-

-

-

-

-

-

-

-

-

Commitments and contingencies (Note 12)

-

-

-

-

-

-

0

-

-

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders' equity
Preferred stock, par value $.0001; 50,000,000 shares authorized; shares issued and outstanding 9,805,845 and 3,594,981, respectively as of March 31, 2020 (unaudited) and June 30, 2019.

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, par value $.0001; 200,000,000 shares authorized; shares issued and outstanding 100,610,380 and 17,538,071, respectively as of March 31, 2020 (unaudited) and June 30, 2019.

10

2

1

1

1

1

0

0

3

0

0

0

1

1

0

0

2

1

1

0

4

554

554

539

0

539

417

417

414

412

412

412

407

407

400

394

388

Additional paid-in capital

202,557

128,619

113,640

113,475

107,893

107,258

92,834

92,681

92,551

80,017

79,667

73,069

-

-

-

56,646

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock subscription

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3

-

-

-

0

-

1

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

70,839

67,548

59,471

-

48,827

39,247

39,064

38,997

13,156

48

47

45

16,026

43

42

41

40

40

38

36

34

31

29

28

27

Ampio stock subscription

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-116,865

-111,532

-111,318

-106,389

-91,857

-87,361

-82,704

-79,257

-79,805

-76,987

-73,314

-69,069

-62,319

-57,103

-52,285

-46,561

-31,263

-23,989

-20,657

-18,381

-12,609

-656

-646

-630

-10,657

-0

-0

-0

-0

-0

-0

-0

-0

-0

-0

-0

-0

Deficit accumulated during development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

618

606

584

568

557

544

530

510

492

480

-470

451

Total stockholders' equity

85,703

17,090

2,323

7,087

16,037

19,897

10,130

13,424

12,750

3,030

6,352

3,999

8,521

10,446

7,186

10,085

17,565

15,258

13,408

15,616

-

-52

-44

-44

5,369

-36

-147

-126

-110

-106

-94

-82

-69

-54

-49

-47

-35

Total stockholders' equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

551

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and stockholders' equity

158,953

74,477

31,024

34,721

38,338

42,399

17,984

21,060

23,374

18,858

21,245

14,998

15,916

21,506

20,200

24,343

21,985

24,409

21,359

18,185

10,201

7

11

5

12,016

13

5

7

9

9

13

11

12

14

16

18

22